When a marketing result isn't clear yet, tell the board what you see, what you think it means, what else could explain it, how you'll check, and when you'll come back with an answer. A board can work with honest uncertainty. It can't make a good decision from false precision.

Say product inquiries jump right after a launch. That might mean real interest from target buyers. It might also be one distributor's promo, a change in tracking or a one-time event. The jump in inquiries is what you see. "The launch is working" is your read on it. Keep those in separate sentences.

Use a five-part uncertainty note

  1. What we see: what moved, over what time period, and where the data came from.
  2. What we think it means: management's current read, said plainly as a read, not a fact.
  3. What else could explain it: other explanations that could change the decision.
  4. What we'll check: the customer, sales, financial or operations evidence that will tell them apart.
  5. When we'll be back: an owner and a date.

EY's board effectiveness framework calls for decision-ready materials that show assumptions, trade-offs, sources and limits. [1] This five-part note is how I put that into practice. It gives directors a clear way to test the thinking while management keeps running the work.

Be clear about data quality

At one company I worked with, the CRM was there, but sales wasn't using it. Any forecast built on those records looked more exact than it really was. We didn't need a prettier chart. We needed to connect the systems and train the team. Once we did, forecast accuracy improved 63%.

That's also why I flag any change in definitions or data collection. If "qualified opportunity" has a new rule, or a new system catches inquiries the old one missed, show where the trend breaks. The SEC's guidance on key performance indicators stresses context around definitions and calculation changes. [2] A private board packet isn't an SEC filing, but the same honesty applies.

Uncertainty doesn't always mean waiting. You might recommend a small test while you gather better evidence, or set a point where you'd pause the investment. Spell out the risk of waiting and the risk of moving too soon. And be clear about which call is management's and which, if any, needs board approval.

The sentence I want directors to hear: "Here's what we know, what we think it means, what could change our minds, and when we'll bring the evidence back." That's real leadership. A confident claim the data can't back up isn't.